Share Name Share Symbol Market Type Share ISIN Share Description
Woodford Patient Capital Trust LSE:WPCT London Ordinary Share GB00BVG1CF25 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.55p +0.60% 92.30p 92.10p 92.30p 92.50p 91.70p 91.70p 1,060,393.00 16:35:08
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 2.4 1.5 0.3 369.2 763.32

Woodford Patient Capital Share Discussion Threads

Showing 1051 to 1073 of 1075 messages
Chat Pages: 43  42  41  40  39  38  37  36  35  34  33  32  Older
DateSubjectAuthorDiscuss
28/2/2017
08:22
PRTA up 8% overnight, PURP going great guns recently, could WPCT wake from the doldrums.
mad foetus
27/2/2017
20:09
"As a cynic I would say a way for management to possibly mentain a book value until something seriously goes wrong with thee unlisted investment and they have to write down the value." Yes, I would have the same view. You just have to remember that unlisted securities are valued by only a handful of people with a greater influence on perceived valuation from those in the business - founders and seed investors. Much of this happens before there is real opportunity for the valuations to be proven or realized. This is at the opposite side of the spectrum to fully listed business where the product or service - at that point - has sold and where the valuation is the market involving many thousands of participants. Use it in this case as a very loose yardstick. As the small businesses develop the correlation between the NAV and underlying assets will improve.
minerve
27/2/2017
19:07
Toffeeman- Certainly for start-up. It is usual to value the share price at the price per share pbtined in the last round of financing. If no round after the initial finaancing then at the share price obtined during the initial round, This can cause accounting glitches where the the last round was say in convertible prefs or loan stock with a high coupon.
pugugly
27/2/2017
19:01
I assume it's regulation to post nav - but it must be open to interpretation
toffeeman
27/2/2017
18:24
Toffeeman - As a cynic I would say a way for management to possibly mentain a book value until something seriously goes wrong with thee unlisted investment and they have to write down the value.
pugugly
27/2/2017
13:48
Someone please explain the relevance of net asset value (and so discount/premium to NAV), when about 50% of the portfolio is unquoted securities?
toffeeman
26/2/2017
12:16
Citywire article today Worth a look re long term http://bit.ly/2l3uHVf
pugugly
24/2/2017
11:21
hxxps://woodfordfunds.com/words/blog/introducing-woodford-income-focus-fund/?utm_source=blog-alert&utm_medium=email&utm_campaign=intro-wiff
tim 3
23/2/2017
11:25
On a positive note... Purplebricks up over 15% today following £50mil placing this morning. Share Price has almost doubled in 3 months. WIM holds 29% of PURP.
woodpecker25
05/2/2017
19:17
V unusual for any trust to have such a large chunk of nav in a single company as WPCT does in Prothena. I hope the board is being sensible. PRTA's full year results are out on the 14th, along with a webcast to listen in on. htTP://ir.prothena.com/index.cfm#ndq-tab-4 I see that across all his accounts Mr W holds just under 30% of PRTA ie approx $0.5bn of it. Certainly a big bet! hTTp://investors.morningstar.com/ownership/shareholders-major.html?t=PRTA
rambutan2
24/1/2017
18:55
Yes. Patience. Even at 150p+ there is still likely to be a discount to NAV.
p1nkfish
24/1/2017
13:20
Discount to NAV and under the original offer price. Is this ever likely to reach £1 again ?
tyranosaurus
20/1/2017
09:46
See that MTPH has issued a positive RNS this AM (Up over 10% at the mo).... one of WPCT holdings.
gwatson56
13/1/2017
19:34
Small pharma should be fine so long as they Innovate. Small are not rippling anyone off on pricing.
p1nkfish
13/1/2017
08:55
I can see some US pharmas doing their research oversea's to avoid what it might perceive hostile future legislation.
netnut
12/1/2017
23:48
Questor buy tip, eh? Is this a clear sell signal? Presumably Questor doesn't believe that Trump wants Pharmas to play more fairly. Good luck with that. Maybe WPCT would be best staying clear of speculative Pharmas for the next 4 years if it ever wants to hit the heady heights of break-even-from-IPO.
fjgooner
12/1/2017
11:04
WPCT tipped by Questor (Daily Telegraph) today, citing attractiveness of current 5% discount to NAV.
woodpecker25
11/1/2017
19:19
LK is a fantastic poster as long as you have him/her filtered ):
toffeeman
10/1/2017
21:10
Liquid Faeces, are your postings so incoherent because you mitched from school a lot? Or is it because you are fundamentally thick?
kpo115
10/1/2017
15:52
WPCT are diverse enough to help in the case of general market drawdowns and the unlisted elements can help in that regard. I don't see 10% p.a., likely to be much lumpier and the real return when the ipo market is ready and/or various global problems are washed away or defaulted upon. Between now and then it's worth accumulating imho. It is less volatile than IPO too.
p1nkfish
10/1/2017
13:38
TAM - No, I have him filtered, because I don't want to read his posts, nor do I want to read the posts of people who comment on them. My last remark on the matter.
jonwig
10/1/2017
13:34
~~ADVFN*MODERATEDIsn't it nice to be on a WPCT thread where the air is pure and free from LQ's bewildered incomprehensible ramblings?
the air marshall
10/1/2017
13:12
kpo - "Ignore ..." Yes: why don't you? If you filter, then ignore, completely ignore, he will be invisible. What your post (and others like it) does is encourage him. Of course, one can also filter people who post about his posts ...
jonwig
Chat Pages: 43  42  41  40  39  38  37  36  35  34  33  32  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20170325 21:48:35